Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis

By Jones Takako Iida   Chen Jennifer C. J.   Rahimov Fedik   Homma Sachiko   Arashiro Patricia   Beermann Mary Lou   King Oliver D.   Miller Jeffrey B.   Kunkel Louis M.   Emerson Charles P.   Wagner Kathryn R.   Jones Peter L.  

Human Molecular Genetics, Vol. 21, Iss. 20, 2012-10 ,pp. : 4419-4430

Oxford University Press

Access to resources Recommend Favorite

Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q

By Jiang Guanchao  

Human Molecular Genetics, Vol. 12, Iss. 22, 2003-11 ,pp. : 2909-2921

Oxford University Press

Access to resources Recommend Favorite

Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD)

By Ansseau Eugénie   Vanderplanck Céline   Wauters Armelle   Harper Scott Q.   Coppée Frédérique   Belayew Alexandra  

Genes, Vol. 8, Iss. 3, 2017-03 ,pp. : 93-93

MDPI

Access to resources Recommend Favorite

Cytogenetic and immuno-FISH analysis of the 4q subtelomeric region, which is associated with facioscapulohumeral muscular dystrophy

By Yang Fan   Shao Chunbo   Vedanarayanan Vettaikorumakankav   Ehrlich Melanie  

Chromosoma, Vol. 112, Iss. 7, 2004-05 ,pp. : 350-359

Springer Publishing Company

Access to resources Recommend Favorite

Inter- and intrachromosomal sub-telomeric rearrangements on 4q35: implications for facioscapulohumeral muscular dystrophy (FSHD) aetiology and diagnosis

By Padberg G.W.  

Human Molecular Genetics, Vol. 7, Iss. 8, 1998-08 ,pp. : 1207-1214

Oxford University Press

Access to resources Recommend Favorite